Alfredo
Martínez Hernández
Researcher to 2023
Mariana
Elorz Carlón
Colaboradora Clínica
Publications by the researcher in collaboration with Mariana Elorz Carlón (17)
2024
-
Circulating miR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p as potential predictive biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease assessment
Journal of Physiology and Biochemistry
-
Circulating microRNA panels in subjects with metabolic dysfunction-associated steatotic liver disease after following a 2-year dietary intervention
Journal of Endocrinological Investigation
-
Inflammatory markers as diagnostic and precision nutrition tools for metabolic dysfunction-associated steatotic liver disease: Results from the Fatty Liver in Obesity trial
Clinical Nutrition, Vol. 43, Núm. 7, pp. 1770-1781
2022
-
A nutrigenetic tool for precision dietary management of non-alcoholic fatty liver disease deeming insulin resistance markers
Panminerva medica, Vol. 64, Núm. 4, pp. 485-496
-
Neck Circumference for NAFLD Assessment during a 2-Year Nutritional Intervention: The FLiO Study
Nutrients, Vol. 14, Núm. 23
2021
-
Dietary intake of specific amino acids and liver status in subjects with nonalcoholic fatty liver disease: fatty liver in obesity (FLiO) study
European Journal of Nutrition, Vol. 60, Núm. 4, pp. 1769-1780
-
Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study
European Journal of Nutrition, Vol. 60, Núm. 6, pp. 3043-3057
-
Effects of two personalized dietary strategies during a 2-year intervention in subjects with nonalcoholic fatty liver disease: A randomized trial
Liver International, Vol. 41, Núm. 7, pp. 1532-1544
-
Three different genetic risk scores based on fatty liver index, magnetic resonance imaging and lipidomic for a nutrigenetic personalized management of nafld: The fatty liver in obesity study
Diagnostics, Vol. 11, Núm. 6
2020
-
Association of the SH2B1 RS7359397 gene polymorphism with steatosis severity in subjects with obesity and non-alcoholic fatty liver disease
Nutrients, Vol. 12, Núm. 5
-
Effects of a 6-month dietary-induced weight loss on erythrocyte membrane omega-3 fatty acids and hepatic status of subjects with nonalcoholic fatty liver disease: The Fatty Liver in Obesity study
Journal of Clinical Lipidology, Vol. 14, Núm. 6, pp. 837-849.e2
-
Predictive Value of Serum Ferritin in Combination with Alanine Aminotransferase and Glucose Levels for Noninvasive Assessment of NAFLD: Fatty Liver in Obesity (FLiO) Study
Diagnostics, Vol. 10, Núm. 11
2019
-
Association between Different Animal Protein Sources and Liver Status in Obese Subjects with Non-Alcoholic Fatty Liver Disease: Fatty Liver in Obesity (FLiO) Study
Nutrients, Vol. 11, Núm. 10
-
Association between sleep disturbances and liver status in obese subjects with nonalcoholic fatty liver disease: A comparison with healthy controls
Nutrients, Vol. 11, Núm. 2
-
The metabolic and hepatic impact of two personalized dietary strategies in subjects with obesity and nonalcoholic fatty liver disease: The fatty liver in obesity (FLiO) randomized controlled trial
Nutrients, Vol. 11, Núm. 10
-
Ultrasound/elastography techniques, lipidomic and blood markers compared to magnetic resonance imaging in non-alcoholic fatty liver disease adults
International Journal of Medical Sciences, Vol. 16, Núm. 1, pp. 75-83
2018
-
Interplay of glycemic index, glycemic load, and dietary antioxidant capacity with insulin resistance in subjects with a cardiometabolic risk profile
International Journal of Molecular Sciences, Vol. 19, Núm. 11